Dr. Alexander K. Nussbaum studied biochemistry in Tübingen, Germany, and the USA. He conducted 10 years of immunological research on vaccines against viral infections and tumors in Germany, the USA and France. At the time, he held lectures on cancer, in which he recommended his audience to stop smoking to avoid home-made risks of cancer.
After spending 8+ years in Medical Affairs roles in the pharmaceutical industry in the fields of autoimmunity and cancer, Dr. Nussbaum joined Philip Morris Germany in December 2016. As Head of Scientific & Medical Affairs he engages with scientific and medical communities, media, authorities and the broader public on PMI´s scientific assessment program and tobacco harm reduction. He is convinced that novel, potentially risk-reduced products offer a historic opportunity for the prevention of smoking-related diseases and thus hold enormous potential for public health.